US2012294896A1PendingUtilityA1
Methods and Compositions for Poxvirus A35R Protein
Est. expiryMar 1, 2026(expired)· nominal 20-yr term from priority
Inventors:Rachel Roper
C12N 2710/24122A61K 39/285A61K 48/0008C12N 2710/24162C12N 7/00A61K 39/12A61P 35/00A61P 37/02C12Q 1/701
42
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides methods and compositions for modulating an immune response in a subject, comprising administering to the subject an effective amount of an A35R protein or active fragment thereof of vaccinia virus or other poxvirus.
Claims
exact text as granted — not AI-modified1 . A method of modulating an immune response in a subject, comprising administering to the subject an effective amount of an A35R protein or active fragment thereof of vaccinia virus or other poxvirus.
2 - 29 . (canceled)Join the waitlist — get patent alerts
Track US2012294896A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.